Sökning: WFRF:(Ramaekers M) >
Psychopathological ...
Psychopathological symptoms associated with synthetic cannabinoid use : a comparison with natural cannabis
-
- Mensen, Vincent T. (författare)
- Department of Drug Monitoring, Utrecht, The Netherlands
-
- Vreeker, Annabel (författare)
- University Medical Center Utrecht, Department of Psychiatry, University of Utrecht, Utrecht, The Netherlands
-
- Nordgren, Johan (författare)
- Malmö universitet,Institutionen för socialt arbete (SA)
-
visa fler...
-
- Atkinson, Amanda (författare)
- Public Health Institute, Liverpool John Moores University, Liverpool, UK
-
- de la Torre, Rafael (författare)
- Integrative Pharmacology and Systems Neurosciences, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
-
- Farré, Magi (författare)
- Integrative Pharmacology and Systems Neurosciences, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Bellaterra, Spain
-
- Ramaekers, Johannes G. (författare)
- Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands
-
- Brunt, Tibor M. (författare)
- Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands; Department of Developmental Psychopathology, Radboud University, Nijmegen, The Netherlands
-
visa färre...
-
(creator_code:org_t)
- 2019-04-09
- 2019
- Engelska.
-
Ingår i: Psychopharmacology. - : Springer. - 0033-3158 .- 1432-2072. ; 236:9, s. 2677-2685
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://mau.diva-por... (primary) (Raw object)
-
https://link.springe...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world throughout recent years. Many different synthetic cannabinoid analogues are on the consumer market and sold under misleading names, like Bspice^ or Bincense.^ A limited number of studies have reported serious health effects associated with SC use. In this study, we compared clinical and subclinical psychopathological symptoms associated with SC use and natural cannabis (NC) use. Methods: A convenience sample of 367 NC and SC users was recruited online, including four validated psychometric questionnaires: The Drug Use Disorders Identification Test (DUDIT), Insomnia Severity Index (ISI), Altman Mania Scale (Altman), and Brief Symptom Inventory (BSI). The two groups were compared with analysis of variance (ANOVA) and covariance (ANCOVA), chi2 tests, and logistic regression when appropriate. Results: The SC user group did not differ in age from the NC user group (27.7 years), but contained less females (21% and 30%, respectively). SC users scored higher than NC users on all used psychometric measures, indicating a higher likelihood of drug abuse, sleep problems, (hypo)manic symptoms, and the nine dimensions comprising the BSI, somatization, obsessivecompulsive behavior, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. Odds ratios (95% CI) for the SC user group vs NC user group were, respectively, drug dependence 3.56 (1.77–7.16), (severe) insomnia 5.01 (2.10–11.92), (hypo-)mania 5.18 (2.04–13.14), and BSI psychopathology 5.21 (2.96–9.17). Discussion: This study shows that SC use is associated with increased mental health symptomatology compared to NC use.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas